The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Neoplasms; Benzamides; Sulfonamides; Pyrazines; Neurofibromin 2; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male
PubMed ID
39693587
PubMed Central ID
PMC11803527
Added to directory
Source checked

Report a correction or request removal